The BCR works closely with hospitals and laboratories in the context of cancer registration. 
In the context of screening, collaboration with other partners deserves to be highlighted 🤝:

• the Intermutualistic Agency[1]
• and regional screening organizations and the regional authorities:
• BRUPREV | Vivalis (Brussels)
• CCRef | AVIQ (Wallonia)
• Centre for Cancer Detection (CvKO) | Departement Zorg (Flanders)

All data are centralised at BCR:

Through regular and structured data exchanges, these partnerships help to:

✅ strengthen data completeness
✅ improve the quality and accuracy of collected information
✅ support more effective screening strategies
✅ assess the performance of the existing programs.

One of the missions of the BCR is to evaluate the screening programs through the calculation of indicators. The analyses concern participation, coverage and overdiagnosis, quality indicators related to cancer diagnosis, follow-up and treatment among the target population…

Monitoring and Evaluation

Annual reports with results of regional cancer screening programmes are published or can be assessed through our website:

📰 Breast: Publications | Belgian Cancer Registry

📰 Colo-rectum: Publications | Belgian Cancer Registry

📰 Cervix: Publications | Belgian Cancer Registry

The BCR has a central position within this ecosystem and collaborates with Belgian partners for a better organization of cancer screening in Belgium, benefiting patients and public health.

The BCR and the screening organizations also collaborate at the international level and have an active contribution in WP5 of the Joint Action EUCanScreen,

• for the collection and reporting of aggregated data (tasks 5.2-5.3)
• for the planned pilot data collection based on individual data (tasks 5.4-5.5)
  • within Belgium, some preparatory work and discussions has been initiated
  • a collaborative effort will allow maximally participating to the pilot data collection

The Belgian partners also actively contributed to the previous CanScreen-ECIS project:

• selection of a set of indicators describing the different phases of the screening process
• pilot data collection: active contribution for all existing organized screenings in Belgium
  • qualitative surveys
  • quantitative surveys

💡 A strong example of how collaboration turns data into meaningful impact for prevention and data excellence!

[1] The InterMutualistic Agency (IMA) brings together patient data from the seven Belgian mutual insurance organizations and prepares them for analytical purposes. The IMA databases contain, in addition to demographic and socio-economic data relating to all residents affiliated with the compulsory health insurance in Belgium, billing data for reimbursed healthcare services.